Skip to content

Avanos Medical AVNS Proceeds from RH divestiture post-closing settlement

Proceeds from RH divestiture post-closing settlement at other companies

PepsiCo logo
PepsiCoPEP
$9.75M-76.5%
Leggett & Platt logo
Leggett & PlattLEG
$10.1M+80.4%
Amcor logo
AmcorAMCR
$0-100%
US Foods logo
US FoodsUSFD
$0-100%
TDA
USA TODAY Co., Inc.TDAY
$9.26M-80.9%
Tetra Tech logo
Tetra TechTTEK
$970.75K

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept avns:ProceedsFromRHDivestiturePostClosingSettlement.

The official record: Avanos Medical’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's proceeds from rh divestiture post-closing settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's proceeds from RH divestiture post-closing settlement?
Avanos Medical (AVNS) reported proceeds from RH divestiture post-closing settlement of $0 in Q4 2025.
How has Avanos Medical's proceeds from RH divestiture post-closing settlement changed year-over-year?
Avanos Medical's proceeds from RH divestiture post-closing settlement decreased by 100.0% year-over-year, from $525K to $0.
What does proceeds from RH divestiture post-closing settlement mean?
Cash inflows received from the final settlement or adjustments related to the divestiture of a business unit or product line. This metric captures non-recurring liquidity events resulting from the optimization of the company's portfolio.